Profil
Jia Li Yuan currently works at Duality Biotherapeutics, Inc., as Joint Secretary from 2024.
Ms. Yuan also formerly worked at Shanghai Fosun Pharmaceutical (Group) Co., Ltd., as Senior Director-Legal and Taizhou EOC Pharma Co., Ltd., as Head-Legal from 2022 to 2023.
Ms. Yuan received her graduate degree in 2017 from the University of Tokyo and graduate degree in 2009 from Shanghai Institute of Foreign Trade.
Postes actifs de Jia Li Yuan
| Sociétés | Poste | Début |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Secrétaire Général | 12/08/2024 |
Anciens postes connus de Jia Li Yuan
| Sociétés | Poste | Fin |
|---|---|---|
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures anticancer drugs | Conseiller Juridique Général | 01/07/2023 |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Conseiller Juridique Général | - |
Formation de Jia Li Yuan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines, pharmaceuticals and medical equipment | Health Technology |
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Institute of Foreign Trade
Shanghai Institute of Foreign Trade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures anticancer drugs | Health Technology |
Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
















